SCHEMBL30452680

SCHEMBL30452680

O=C(O)Cc1ccc(I)nc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.61
GABRD O14764 2/20 0.61
GABRA1 P14867 2/20 0.61
GABRB1 P18505 2/20 0.61
GABRG2 P18507 2/20 0.61
GABRB3 P28472 2/20 0.61
GABRA5 P31644 2/20 0.61
GABRA3 P34903 2/20 0.61
GABRA2 P47869 2/20 0.61
GABRB2 P47870 2/20 0.61
GABRA4 P48169 2/20 0.61
GABRE P78334 2/20 0.61
GABRA6 Q16445 2/20 0.61
GABRG1 Q8N1C3 2/20 0.61
GABRG3 Q99928 2/20 0.61
GABRQ Q9UN88 2/20 0.61
P4HTM Q9NXG6 2/20 0.61
NAPRT Q6XQN6 1/20 0.48
CA2 P00918 2/20 0.47
CAMK2A Q9UQM7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2994079 1.00 GABRP (0.61) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31716303 0.82 P4HTM (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20037765 0.82 CA2 (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20037783 0.81 P4HTM (0.64) P4HTMCA2LMNAFFAR1
SCHEMBL31715984 0.78 RAB9A (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3008213 0.78 RAB9A (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12844891 0.78 HDAC4 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20037801 0.78 SMN1; SMN2 (0.52) GABRA1GABRA2GABRB2P4HTMLMNA
SCHEMBL5740064 0.78 GABRP (0.63) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14671128 0.77 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245472-A1 COMPOUNDS AND RELATED METHODS USEFUL FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-11-27 WO disclosed
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 WO disclosed
CN-111484479-B Azacyclic compounds, pharmaceutical compositions containing the same, and methods of making and using the same 四川科伦博泰生物医药股份有限公司 2023-06-13 CN disclosed